• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Worst mistake EVER was merging with Sh!tting Plough

Second hand drug for a second hand company.

BMS will beat Merck with this and again this company will be playing second fiddle to others who know how to run a decent company


I went for interview at BMS last week and got the chance to review their pipeline. Their top selling drugs are either out of patent protection or going to in 1 year. I thought BMS was in a terrible shape. It brought and sold Amylin.
Do you know if BMS has some secret weapon in their pipeline? enlighten me
 




Merck was on the verge of being sold, "bought" after Vioxx. This company was one step from being out due to FDA and lying about Vioxx. Why do you think Merck can not get anything through FDA. It was lying to FDA. Wise up Merck's time has come. If Merck cleaned house the FDA would let up..
 








You are such a loser and so out of it that you do not realize that was the best thing that ever happened to Merck. Check the pipeline and products pending approval not to mention the stuff up for sale or divisions to be sold off. This was the best thing to happen to Merck to save this sinking ship and I am grateful that I am on a lifeboat and I am able to sail off while this shit sinks.

FU
 












How do you feel the Organon people feel? Not only were we sold to a worse company, Schering Plough, then the worst company possible Merck comes and ruins two companies. Merck blows and if it was a good company, that must of been 40 years ago.
 




Here is the story:
Merck and Schering-Plough were both very good companies. The issue was scalability. The upper management screwed it up. They never saw the big picture. They did not understand how to manage all the moving parts. They had no clue what they were doing and never provided middle management any guidance. People were willing to work hard. The issue was people did not know what to do. Everything was kind of in a holding pattern. Projects were being shuffled all over the place. There was no commitment from upper management to move forward. People who had ideas were seen as a threat. I think it was more because they just got tired of doing busy work.
Culture:
Schering-Plough employees were the nicer people. They were not prepared and could not handle how Merck's culture. They got bum rushed. They really had no chance. Merck management really knows how to play the game, change the rules during the game, and somehow still play the victim.
If Merck and SP played a football game, somehow all the refs would also be from Merck. A Merck receiver would catch the ball at the 50 yard line 5 yards out of bounds and the ref would call it a reception. SP would argue the call and get a flag for unsportsmanlike conduct. Then the Merck refs would call it a touchdown and eject the SP players. It was a no win situation.

All that would have never happened if upper management understood anything about scale and guidance. They were the ones that caused the culture clash. Middle management and lower were lost once the ink dried on the merger. Both Merck and SP upper management failed.
 




How do you feel the Organon people feel? Not only were we sold to a worse company, Schering Plough, then the worst company possible Merck comes and ruins two companies. Merck blows and if it was a good company, that must of been 40 years ago.

Should have stayed overseas. Merck wasn't that bad. All depends on the cool aid you choose.
 








Here is the story:
Merck and Schering-Plough were both very good companies. The issue was scalability. The upper management screwed it up. They never saw the big picture. They did not understand how to manage all the moving parts. They had no clue what they were doing and never provided middle management any guidance. People were willing to work hard. The issue was people did not know what to do. Everything was kind of in a holding pattern. Projects were being shuffled all over the place. There was no commitment from upper management to move forward. People who had ideas were seen as a threat. I think it was more because they just got tired of doing busy work.
Culture:
Schering-Plough employees were the nicer people. They were not prepared and could not handle how Merck's culture. They got bum rushed. They really had no chance. Merck management really knows how to play the game, change the rules during the game, and somehow still play the victim.
If Merck and SP played a football game, somehow all the refs would also be from Merck. A Merck receiver would catch the ball at the 50 yard line 5 yards out of bounds and the ref would call it a reception. SP would argue the call and get a flag for unsportsmanlike conduct. Then the Merck refs would call it a touchdown and eject the SP players. It was a no win situation.

All that would have never happened if upper management understood anything about scale and guidance. They were the ones that caused the culture clash. Middle management and lower were lost once the ink dried on the merger. Both Merck and SP upper management failed.

Agreed. Merck Moron Management screwed everyone.
 








Come back with that in a few days that Consumer is sold for 15 billion.

The "Reverse Merger" took place over four years ago. So, actually Merck is being sold for "parts," as indicated by the Consumer sale. Thank God we had Dr. Scholls's and Coppertone from Schering-Plough to even get anyone to purchase our Consumer book of business.
 




The "Reverse Merger" took place over four years ago. So, actually Merck is being sold for "parts," as indicated by the Consumer sale. Thank God we had Dr. Scholls's and Coppertone from Schering-Plough to even get anyone to purchase our Consumer book of business.

These sales and firing people are the only thing keeping Merck afloat. Merck doesn't have any parts that companies would want to buy. Sorry Merck robots.
 




You should have looked into the future pipeline as the merger happened and realized the focus of merck in 5 years were specialty products that make money. The layers of primary care were sinking The company and the drugs are not as profitable especially when you have salesforces of 65-150 people vs primary care which has 1000's. You should pay more attention at the plotee business briefings and listened to pipeline. Merck had no products in the pipeline without a merger there was no future. The future changed to specialty care and primary care is slowly working its way out year by year. Look at the writing on the wall every company is realizing they don't need primary care the division has been ruined by over hiring and doctors don't have time to see 20-30 different reps from various companies everyday. Too much overlap in management and sales. Primary care became robots selling and believing whatever got thrown at you quarterly. The big picture has been here all along you chose to live in fantasy land repeating sales messages, not thinking for yourself and getting micromanaged for years. If you get laid off don't go back into primary care you will be weeded out everywhere soon enough. There's less profits and companies are all realizing the market changes. If you are in specialty you have as long as the pipeline invests in future advances or another company launches a better easier drug. Watch your own back the bottom line is no one cares about you if your division isn't bringing in money - if there is no future investment figure on getting consolidated or laid off... The industry changed 5-10 years ago some people are just figuring out now what happened with the schering merck merger. That's your own fault for drinking the cool aid and not figuring out what the merger was for- PIPELINE specialty products and what could be sold off for profits as future patent losses happened. Good luck everyone
 
















One does not need to listen to some company's "schtick" when they can read the scientific literature for a more balanced and insightful view. Anticancer antibody therapies that work through checkpoint-blocking will expose immune-related adverse events resulting from breaking immune tolerance. I will patiently wait to read about these issues once these drugs get out of the controlled environment of a clinical study.
 




Merging with Merck was the best thing Schering Plough ever did....really .I made millions and millions so it must have been great. The hardest part was not laughing out loud at the meetings. I figured some one would eventually figure out Schering had no pipeline. Suggamadex still not approved...Saphris...really..... Suvorexant..... may never get to market. Other drugs never even made it to Stage 3 clinical trials. Wait till the enhance data comes out in Sept. Like we don't already know what its going to conclude. Thank you Merck for the millions!!!

Sincerely,

Fast Freddie Hassan